Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Oncology Reports|January 31, 2025
Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinomaXinyan Geng, Shirin Azarbarzin, Zejia Yang, et al.
Future Medicinal Chemistry|May 12, 2017
Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell linesElizabeth Larocque, N Naganna, Xiaochu Ma, et al.
The Prostate|January 27, 2004
Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiationRena G Lapidus, Wenbin Dang, David Marc Rosen, et al.
Future Medicinal Chemistry|February 14, 2018
Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell linesNeetu Dayal, Clement Opoku-Temeng, Delmis E Hernandez, et al.
Molecular Cancer Therapeutics|May 20, 2016
Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdAYanting Zhang, Rena G Lapidus, Peiyan Liu, et al.
Environmental and Molecular Mutagenesis|July 31, 2020
CD59-deficient bone marrow erythroid cells from rats treated with procarbazine and propyl-nitrosourea have mutations in the Pig-a geneJavier R Revollo, Azra Dad, Mason G Pearce, et al.
Bioorganic & Medicinal Chemistry|January 8, 2013
Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepinesAtul Kondaskar, Shilpi Kondaskar, James C Fishbein, et al.
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
Frontiers in Oncology|December 29, 2022
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycineDominique Bollino, J Preston Claiborne, Kanwal Hameed, et al.
Oral Oncology|June 6, 2022
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinomaZejia Yang, Jipei Liao, Lisa Schumaker, et al.
Pageof 7